Covid vaccines for children aged six to five years could be rolled out in days as FDA panel meets today to consider approving the shot despite scientists saying they are LEAST at risk from the virus: Cases across the US plateau as deaths fall 36% in a week
Members of the Vaccines and Related Biological Products Advisory Committee convened at 9.30am today to debate whether to sign-off on Moderna and Pfizer shots for the youngest children
They are widely expected to approve both shots in the first stage of a four-part approval process
This is despite concerns raised from many scientists because children face such low risk from Covid
There is also little demand, with less than a third of eligible five to 11-year-olds double-jabbed. A survey also suggests that only 18 percent of parents would come forward to get their child inoculated